DoD Traumatic Brain Injury and Psychological Health, Focused Program Award
ID: 354264Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted May 16, 2024 12:00 AM
  4. 4
    Due Oct 3, 2024 12:00 AM
Description

The Department of the Army -- USAMRAA is offering a grant opportunity titled "DoD Traumatic Brain Injury and Psychological Health, Focused Program Award". This grant aims to accelerate the development of solutions to critical questions related to traumatic brain injury (TBI) and psychological health conditions. The grant supports a multidisciplinary research program that can have a significant impact on these conditions through clinical applications, including healthcare products, technologies, and practice guidelines. The grant encourages applied/preclinical/clinical research, hypothesis-driven health services research, implementation science, and follow-up care research. The grant requires the submission of three to five research projects that address a unifying, overarching challenge relevant to the field of research and patient care. The research projects should be interrelated, synergistic, and capable of producing research findings with the potential to impact the field and/or patient care. The grant also emphasizes the importance of a detailed implementation plan, a robust statistical plan, and the formation of a highly qualified and multidisciplinary research team. The Principal Investigator (PI) is required to devote a minimum of 20% effort to the award and should create an environment that fosters collaboration and innovation. The grant includes a milestone meeting after the conclusion of year 2 of the period of performance, where the PI presents an update on progress. Clinical trials may be designed to evaluate new products, pharmacologic agents, diagnostics, devices, therapies, clinical guidance, behavioral interventions, emerging approaches and technologies, and/or new indications for FDA-approved or -cleared products. The grant provides approximately $46.5 million to fund approximately six applications, with awards to be made by September 30, 2025.

Point(s) of Contact
Files
Title
Posted
5/17/2024
Similar Opportunities
DoD Traumatic Brain Injury and Psychological Health, Translational Research Award
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), has posted a grant opportunity titled "DoD Traumatic Brain Injury and Psychological Health, Translational Research Award." This grant aims to accelerate the conversion of research findings in psychological health and/or traumatic brain injury (TBI) into clinical applications. The funded research outcomes should lead to the development of healthcare products, technologies, and/or clinical practice guidelines that improve patient outcomes. The grant supports translational research, which may include preclinical applied research (including animal research) and clinical research (including pilot/exploratory clinical trials). It may also support ancillary studies associated with ongoing or completed clinical trials and projects that optimize the design of future clinical trials. However, it may not be used to support studies requiring an exception from informed consent (EFIC). The grant specifically focuses on clinical trials that evaluate promising new products, pharmacologic agents, diagnostics, devices, therapies, clinical guidance, behavioral interventions, emerging approaches and technologies, and/or new indications for products currently approved or cleared by the U.S. Food and Drug Administration (FDA). Basic research is not allowed. Applicants are required to include preliminary and/or published data to support their proposed research project. The grant allows funding for a pilot/exploratory clinical trial as part of the research project, but large-scale clinical trials or multiple pilot/exploratory clinical trials are not eligible. For the purposes of this funding opportunity, clinical research is distinguished from clinical trials. Clinical research encompasses research with human data, human specimens, and/or interaction with human subjects, while clinical trials specifically evaluate the effects of interventions on biomedical or behavioral health-related outcomes. The grant also provides additional submission requirements and review criteria for applications that include a clinical trial. Funded clinical trials are required to post a copy of the informed consent form used to enroll subjects on a publicly available federal website. If the proposed research involves more than one U.S.-based institution, a written plan for single Institutional Review Board (IRB) review arrangements must be provided. The lead institution responsible for developing the master protocol and master consent form should be identified, and communication and data transfer between collaborating institutions should be addressed. The grant offers funding for two Research Levels, with Research Level 1 supporting smaller scope, less complex preclinical and/or clinical research, and Research Level 2 supporting larger scope, more complex preclinical and/or clinical research. Research Level 2 also includes an Early-Career Investigator Partnering Option, allowing two Principal Investigators (PIs), one of whom must be an Early-Career Investigator, to collaborate on the research project. All projects funded by the grant should adhere to a core set of standards for rigorous study design and reporting to maximize the reproducibility and translational potential of preclinical research. Animal research plans should be submitted for projects involving animal models. Relevance to military health is a key feature of this grant, and investigators are encouraged to address aspects of psychological health conditions and/or TBI that have direct relevance to the health and readiness of Service Members, their Families, and Veterans. Collaborations between military or Veterans organizations and non-military organizations are strongly encouraged. The estimated total program funding for this grant opportunity is $17,050,
DOD Traumatic Brain Injury and Psychological Health, Emerging Topics Research Award
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), has posted a grant opportunity titled "DOD Traumatic Brain Injury and Psychological Health, Emerging Topics Research Award." This grant aims to accelerate research in emerging topics related to traumatic brain injury (TBI) and/or psychological health. The findings from this research should ultimately support the development of new or updated clinical applications, healthcare products, and clinical practice guidelines for Service Members, their Families, Veterans, and the American public. The research scope for this grant includes preclinical applied research (including animal research) and clinical research (including clinical trials). However, basic research is not eligible for funding. The grant may also support ancillary studies associated with ongoing or completed clinical trials, as well as projects that optimize the design of future clinical trials. It should be noted that this award cannot be used to support studies requiring an exception from informed consent (EFIC). The grant is specifically interested in funding clinical trials that evaluate promising new products, pharmacologic agents, diagnostics, devices, therapies, clinical guidance, behavioral interventions, emerging approaches and technologies, and/or new indications for products currently approved or cleared by the U.S. Food and Drug Administration (FDA). Applicants should be aware that there are additional submission requirements and review criteria for applications that include a clinical trial. If recommended for funding, funded clinical trials are required to post a copy of the informed consent form used to enroll subjects on a publicly available federal website. For multi-institutional clinical research/trials, U.S. institutions engaged in non-exempt cooperative research must rely on a single Institutional Review Board (IRB) to review and approve the portion of the research conducted at domestic sites. A written plan for single IRB review arrangements must be provided at the time of application submission or award negotiation. The grant offers funding for two Research Levels. Research Level 1 supports smaller scope, less complex preclinical clinical research, or pilot/exploratory clinical trials with a maximum period of performance of 3 years and a direct costs budget not exceeding $700,000. Research Level 2 supports larger scope, more complex preclinical clinical research, or clinical trials with a maximum period of performance of 4 years and a direct costs budget not exceeding $1.5 million. For Research Level 2, there is an Early-Career Investigator Partnering Option available, which allows for two Principal Investigators (PIs), one of whom must be an Early-Career Investigator. The combined direct costs budgeted for the entire period of performance should not exceed $1.5 million. The PIs should contribute significantly to the development of the proposed research project, and the application should describe how their unique experience and expertise as a partnership will better address the research question. All projects should adhere to a core set of standards for rigorous study design and reporting to maximize the reproducibility and translational potential of preclinical research. Animal research plans should be submitted for projects that include research on animal models. Relevance to the health care needs of Service Members, their Families, and Veterans is a key feature of this grant. Investigators are encouraged to demonstrate how their projects address psychological health conditions and/or TBI with direct relevance to the health and readiness of Service Members
DoD Traumatic Brain Injury and Psychological Health, Clinical Trial Award
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), has posted a federal grant notice titled "DoD Traumatic Brain Injury and Psychological Health, Clinical Trial Award." This grant opportunity falls under the category of Science and Technology and other Research and Development. The grant aims to support the rapid implementation of clinical trials that have the potential to significantly impact psychological health conditions and/or Traumatic Brain Injury (TBI) through clinical applications, including healthcare products, technologies, and practice guidelines. The proposed research can be aligned with TBI, psychological health, or a combination of both. Clinical trials may evaluate promising new products, pharmacologic agents (drugs or biologics), diagnostics, devices, therapies, clinical guidance, behavioral interventions, emerging approaches and technologies, and/or new indications for products currently approved or cleared by the U.S. Food and Drug Administration (FDA). Interventions that are not FDA-regulated but have documented regulatory status are also within the scope of this grant. The funding from this award mechanism must support a clinical trial, which is defined as a research study in which one or more human subjects are assigned to one or more interventions to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes. The proposed projects can range from small proof-of-concept trials to large-scale trials to determine efficacy in relevant patient populations. The grant requires the inclusion of preliminary data relevant to the proposed clinical trial and the use of Community-Based Participatory Research (CBPR) approaches in the development and execution of the trial. The application should demonstrate the availability of and access to a suitable patient population that will support meaningful outcomes. It should also include a discussion of how accrual goals will be achieved and the strategy for inclusion of women and minorities in the clinical trial. The application should demonstrate the availability of and access to the necessary drug/compound, device, and/or other materials for the proposed duration of the study. The study team should have expertise and experience in conducting clinical trials, including statistical analysis, knowledge of regulatory processes, and data management. The application should also show strong institutional support and a commitment to serve as the regulatory sponsor, if applicable. The grant encourages the use of innovative clinical trial design approaches and precision medicine approaches when appropriate. It requires a clearly articulated statistical analysis plan, a power analysis reflecting sample size projections, and a data management plan. If the proposed clinical trial involves the use of a drug or device that has not been approved by the relevant regulatory agency, the submission of an Investigational New Drug (IND) application or Investigational Device Exemption (IDE) application may be required. The applicant is responsible for providing evidence from the Institutional Review Board (IRB) or the relevant regulatory agency if an IND or IDE is not required. The grant offers three research levels with different maximum periods of performance and budget limits. Research Level 1 supports proof-of-principle pilot studies, small phase 1 trials, correlative studies, and other exploratory clinical trials. Research Level 2 supports phase 1 and more advanced clinical trials, while Research Level 3 supports larger-scale clinical trials that demonstrate efficacy in relevant patient populations. Relevance to military health is a key feature of this grant, and investigators are encouraged to address aspects of psychological health conditions